JAK3-selective inhibitor peficitinib for the treatment of rheumatoid arthritis-Reference-Cited by-同舟云学术

JAK3-selective inhibitor peficitinib for the treatment of rheumatoid arthritis

Published:2019-05-13 Issue:6 Volume:12 Page:547-554
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Qiu Qian¹,Feng Qilin¹,Tan Xueying²,Guo Mingxing³

Affiliation:

1. Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

2. College of pharmacy, Zhejiang Pharmaceutical College, Ningbo, China

3. Department of Traditional Chinese Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Funder

Medical and Health Science and Technology Project of Zhejiang Province

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2019.1615443

Reference62 articles.

1. Immunopathogenesis of Rheumatoid Arthritis

2. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

3. Safety profile of biological therapies for treating rheumatoid arthritis

4. What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?

5. Tumour necrosis factor-α blockade: a new era for effective management of rheumatoid arthritis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peficitinib alleviated acute lung injury by blocking glycolysis through JAK3/STAT3 pathway;International Immunopharmacology;2024-05

2. Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis;Archiv der Pharmazie;2024-03-05

3. What can we learn from treatments of oral lichen planus?;Frontiers in Cellular and Infection Microbiology;2024-02-15

4. Machine Learning-Driven Predictions for Janus Kinase 3 Protein Drug Effectiveness;2024 IEEE First International Conference on Artificial Intelligence for Medicine, Health and Care (AIMHC);2024-02-05

5. Conjoint research of WGCNA, single-cell transcriptome and structural biology reveals the potential targets of IDD development and treatment and JAK3 involvement;Aging;2023-12-12